Close

JPMorgan Assumes Karuna Therapeutics Inc. (KRTX) at Overweight

August 1, 2022 5:03 PM EDT
Get Alerts KRTX Hot Sheet
Price: $218.01 --0%

Rating Summary:
    16 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 8
Join SI Premium – FREE

JPMorgan analyst Jessica Fye assumes coverage on Karuna Therapeutics Inc. (NASDAQ: KRTX) with a Overweight rating and a price target of $175.00.


For an analyst ratings summary and ratings history on Karuna Therapeutics Inc. click here. For more ratings news on Karuna Therapeutics Inc. click here.


Shares of Karuna Therapeutics Inc. closed at $130.25 yesterday.


You May Also Be Interested In





Related Categories

New Coverage